BSET Q1 2026 Earnings EPS Falls Short of Estimates Amid Furniture Market Headwinds Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development GRNT Q1 2026 Earnings Sharp EPS Miss Weighs on Investor Sentiment NMIH Q1 2026 Earnings EPS Beats Consensus by 18 Stock Slightly Lower Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss